Orasis Drug Patent Portfolio
Orasis owns 1 orange book drug protected by 4 US patents Given below is the list of Orasis's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10639297 | Ophthalmic pharmaceutical compositions and uses relating thereto | 18 Aug, 2037 | Active |
| US11129812 | Ophthalmic pharmaceutical compositions and uses relating thereto | 18 Aug, 2037 | Active |
| US11974986 | Ophthalmic pharmaceutical compositions and uses relating thereto | 18 Aug, 2037 | Active |
| US9867810 | Ophthalmic pharmaceutical compositions and uses relating thereto | 18 Aug, 2037 | Active |
Latest Legal Activities on Orasis's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Orasis.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 09 Jul, 2025 | US9867810 |
| Mail Patent eCofC Notification | 15 Apr, 2025 | US11974986 |
| Recordation of Patent eCertificate of Correction | 15 Apr, 2025 | US11974986 |
| Email Notification | 15 Apr, 2025 | US11974986 |
| Patent eCofC Notification | 15 Apr, 2025 | US11974986 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 19 Mar, 2025 | US11129812 |
| Patent eCofC Notification | 13 Aug, 2024 | US11129812 |
| Recordation of Patent eCertificate of Correction | 13 Aug, 2024 | US11129812 |
| Email Notification | 13 Aug, 2024 | US11129812 |
| Mail Patent eCofC Notification | 13 Aug, 2024 | US11129812 |
| Email Notification | 26 Jul, 2024 | US11129812 |
| Post Issue Communication - Certificate of Correction | 25 Jul, 2024 | US11129812 |
| Mail Certificate of Correction Memo | 25 Jul, 2024 | US11129812 |
| Certificate of Correction Memo | 24 Jul, 2024 | US11129812 |
| Patent eCofC Notification | 16 Jul, 2024 | US11974986 |
Orasis's Family Patents
Orasis Drug List
Given below is the complete list of Orasis's drugs and the patents protecting them.
1. Qlosi
Qlosi is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10639297 | Ophthalmic pharmaceutical compositions and uses relating thereto |
18 Aug, 2037
(11 years from now)
| Active |
| US11129812 | Ophthalmic pharmaceutical compositions and uses relating thereto |
18 Aug, 2037
(11 years from now)
| Active |
| US11974986 | Ophthalmic pharmaceutical compositions and uses relating thereto |
18 Aug, 2037
(11 years from now)
| Active |
| US9867810 | Ophthalmic pharmaceutical compositions and uses relating thereto |
18 Aug, 2037
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qlosi's drug page